Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 10/20 | 0.40 |
| ▸ | CTSL | P07711 | 7/20 | 0.38 |
| ▸ | CTSB | P07858 | 7/20 | 0.38 |
| ▸ | CTSH | P09668 | 5/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7897574 | 0.79 | CTSK (0.37) | CTSKCTSLCTSBCTSH | |
| SCHEMBL21402639 | 0.77 | TP53 (0.36) | USP2 | |
| SCHEMBL7910227 | 0.77 | CTSK (0.38) | CTSKCTSLCTSBCTSH | |
| SCHEMBL7910234 | 0.77 | CTSK (0.38) | CTSKCTSLCTSBCTSH | |
| Methacrylic Acid SCHEMBL7162656 | 0.75 | CTSK (0.39) | CTSKCTSLCTSBCTSH | |
| SCHEMBL28622321 | 0.75 | ALDH1A1 (0.38) | — | |
| SCHEMBL7906892 | 0.75 | ALDH1A1 (0.38) | — | |
| SCHEMBL7906888 | 0.75 | ALDH1A1 (0.38) | — | |
| SCHEMBL22890900 | 0.74 | SLC6A2 (0.34) | CTSKCTSLCTSBCTSH | |
| SCHEMBL21402584 | 0.73 | CTSK (0.44) | CTSKCTSLCTSBCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110225739-B | Wrinkle-improving agent | 宝丽化成工业有限公司 | 2022-03-15 | — | — | CN | disclosed |
| US-10813859-B2 | Wrinkle ameliorating agent | POLA CHEMICAL INDUSTRIES, INC. (JP) | 2020-10-27 | — | — | US | disclosed |
| EP-3545942-A1 | WRINKLE AMELIORATING AGENT | Pola Chemical Industries Inc. (JP) | 2019-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10813859-B2 | Wrinkle ameliorating agent | COL2A1, COL1A1, COL14A1 | CTSK 1893/4885CTSL 3788/4885CTSB 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.